BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 964 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $316,000 | -96.5% | 3,614 | -97.4% | 0.02% | -96.5% |
| Q4 2017 | $9,049,000 | +2145.4% | 139,995 | +2001.7% | 0.72% | +2146.9% |
| Q2 2017 | $403,000 | +15.5% | 6,661 | -15.5% | 0.03% | +39.1% |
| Q4 2016 | $349,000 | -92.7% | 7,882 | -94.6% | 0.02% | -96.6% |
| Q3 2015 | $4,808,000 | +13.9% | 146,350 | +137.4% | 0.68% | -2.7% |
| Q1 2015 | $4,222,000 | +245.8% | 61,636 | +269.9% | 0.70% | +121.6% |
| Q4 2014 | $1,221,000 | -69.0% | 16,662 | -69.7% | 0.32% | -68.8% |
| Q3 2014 | $3,940,000 | +44.5% | 54,902 | +45.6% | 1.01% | +14.5% |
| Q2 2014 | $2,727,000 | +236.3% | 37,720 | +242.3% | 0.88% | +145.8% |
| Q1 2014 | $811,000 | +5.2% | 11,021 | -0.6% | 0.36% | -32.3% |
| Q4 2013 | $771,000 | -17.0% | 11,087 | -21.6% | 0.53% | -59.2% |
| Q3 2013 | $929,000 | – | 14,146 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |